The latest advances and trends in pDNA production point the way towards scalable and robust process designs that meet the growing demand for high-quality pDNA in therapeutic applications.
Watch the webinar to learn how to:
Enhance robustness and improve contaminant profiles, including genomic DNA and isoform homogeneity, with in-line/continuous lysis
Remove host cell RNA and proteins while concentrating multiple pDNA isoforms (OC, SC, multimers) in the eluate
Implement selective hydrophobic interaction chromatography (HIC) for purity analysis to monitor pDNA quality
Ensure compliance with regulatory standards on pDNA quality